Trial no.:
|
PACTR201707002412282 |
Date of Approval:
|
07/07/2017 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Levobupivacine versus levobupivacine dexmedetomidine in thoracic paravertebral block for laparoscopic sympathectomy |
Official scientific title |
Levobupivacine versus levobupivacine dexmedetomidine in thoracic paravertebral block for laparoscopic sympathectomy |
Brief summary describing the background
and objectives of the trial
|
Pain after sympathectomy is considerable and restriction of chest movement is frequently observed. Successful acute postoperative pain management remains challenging and if not adequately controlled may increase the likelihood of subsequent chronic pain in the operative area, movement restriction and post operative nausea and vomiting (PONV) (luoma et al., 2005) (Hache et al., 2009).
General anesthesia cannot provide postoperative incisional pain control, also general anesthesia (with exception of large doses of opioid) do not eliminate the surgical stress response, aggravate immunosuppresion and may cause undesirable side effects such as nausea and vomiting (Rüsch et al., 2010) ,the routine use of parenteral narcotics in these cases further aggravate the situation. Recovery time is prolonged and hospital stay is lengthened with more hospital costs (Liu et al., 2005).In light of this situation, various regional anesthetic techniques for thoracic surgery have been suggested including field block, local anesthetic infiltration, intercostal nerve block, epidural anesthesia, paravertebral block and brachial plexus block (Klein et al., 2004).
Thoracic paravertebral nerve block (TPVB) can provide high quality analgesia which can be used for patients undergoing many types of surgery, and also for those suffering from trauma pain and chronic pain. Although most clinical reports and research relate to unilateral TPVB, a diversity of publications challenges the assumption that it cannot be applied to midline surgery. Bilateral PVB has been successfully used in the thoracic, abdominal, and pelvic regions.
Many drugs had been used as an adjuvant to local anesthetics in paravertebral block such as dexmedetomidine (precedex). It has a local anesthetic like properties. Moreover , It acts by inhibitory neuronal actions on alpha 2 adrenoceptor decreasing sympathetic tone with attenuation of neuroendocraine and hemodynamic responses to anesthesia and surgery . |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia,palmer hyperhydrosis,Skin and Connective Tissue Diseases,Surgery |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
01/05/2016 |
Actual trial start date |
20/05/2016 |
Anticipated date of last follow up |
30/12/2016 |
Actual Last follow-up date |
01/03/2017 |
Anticipated target sample size (number of participants) |
34 |
Actual target sample size (number of participants) |
34 |
Recruitment status |
Completed |
Publication URL |
|
|